Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Great Point Partners Llc
Form 13F · Q2 2026

Great Point Partners Llc

CIK 1281446申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$5.3亿
申报组合市值
42
持仓数量
12
Quarters on record
Top 50
持仓数量

Great Point Partners Llc——持仓

共 42 个持仓中的前 37 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1VOR Vor Biopharma Inc1.7M−2.9%$3130万5.9%
2ABVX Abivax Sa204,314—$2723万5.1%
3VERA Vera Therapeutics Inc600,836+201.4%$2578万4.9%
4ZURA Zura Bio Ltd4.2M+0.0%$2487万4.7%
5ALMS Alumis Inc856,061+0.0%$2409万4.6%
6SLGL Sol-Gel Technologies Ltd274,363+0.0%$2034万3.8%
7DFTX Definium Therapeutics Inc425,000—$1999万3.8%
8ANNX Annexon Inc3.5M+40.0%$1998万3.8%
9ORKA Oruka Therapeutics Inc183,330+0.0%$1745万3.3%
10MLTX Moonlake Immunotherapeutics855,813+71.2%$1666万3.1%
11SGMT Sagimet Biosciences Inc2.0M—$1569万3.0%
12CTNM Contineum Therapeutics Inc921,481+15.2%$1510万2.9%
13IMMX Immix Biopharma Inc1.3M+265.0%$1317万2.5%
14CLYM Climb Bio Inc1.0M−25.0%$1304万2.5%
15AMLX Amylyx Pharmaceuticals Inc700,000−60.0%$1257万2.4%
16NKTR Nektar Therapeutics175,000−44.7%$1222万2.3%
17NGNE Neurogene Inc352,180−29.6%$1108万2.1%
18LBRX Lb Pharmaceuticals Inc317,221+5.7%$1030万1.9%
19IRD Opus Genetics Inc2.0M+507.4%$810万1.5%
20EPRX Eupraxia Pharmaceuticals Inc1.2M+0.0%$793万1.5%
21DRUG Bright Minds Biosciences Inc109,603−50.2%$769万1.5%
22IFRX Inflarx Nv3.0M—$682万1.3%
23RLMD Relmada Therapeutics Inc842,106+0.0%$583万1.1%
24JATT Jatt Ii Acquisition Corp500,000—$568万1.1%
25CGEM Cullinan Therapeutics Inc300,000+0.0%$546万1.0%
26ALT Altimmune Inc1.7M—$529万1.0%
27AMAN Amanat Acquisition Corp500,000—$508万1.0%
28RZLT Rezolute Inc951,809+0.0%$495万0.9%
29SLN Silence Therapeutics Plc450,000−55.9%$494万0.9%
30PALI Palisade Bio Inc2.3M−32.9%$478万0.9%
31EVMN Evommune Inc325,000+0.0%$432万0.8%
32SCYX Scynexis Inc944,292—$384万0.7%
33ELVN Enliven Therapeutics Inc70,000—$355万0.7%
34HUMA Humacyte Inc3.8M+0.0%$293万0.6%
35RNTX Rein Therapeutics Inc2.6M—$268万0.5%
36DBVT Dbv Technologies S A156,906—$257万0.5%
37PMN Promis Neurosciences Inc86,150−76.8%$113万0.2%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。